Skip to content
GLP-1 Scorecard
Menu
Site position #523

Remedy Meds

Published by GLP-1 ScorecardUpdated

Telehealth provider offering compounded semaglutide and tirzepatide programs.

Visit Remedy MedsWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$299/mo (starting dose, compounded)
Tirzepatide
$399/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Not confirmed

Weigh Remedy Meds against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value36/100
Dose & formulation64/100
Clinical oversight55/100
Labs & monitoring53/100
Fulfillment65/100
Contract terms41/100

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

What to consider

  • Limited public information on program details
  • FDA issued Remedy Meds a warning letter in September 2025; the letter is public in FDA's warning-letter database

Bottom line — Grade C

Best for: Shoppers who want mainstream telehealth GLP-1 access.

Site position #523 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

FDAWarning letter issued to Remedy Meds in September 2025. See the FDA warning-letter database.

Closest here

The rankings grading nearest Remedy Meds — the realistic shortlist.

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Remedy Meds's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Remedy Meds's site. Not medical advice; see our disclosure.

← Back to the scorecard